Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Peripheral Neuritis Treatment Market?

In recent times, there has been significant growth in the size of the peripheral neuritis treatment market. The market, which was valued at $1.84 billion in 2024, is expected to surge to $1.93 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.1%. Factors contributing to the historic rise include an uptick in healthcare spending, a hike in chronic diseases, an increased disease burden related to peripheral neuritis, a higher incident rate among diabetic patients, and a growing elderly population.

In the coming years, the market size for peripheral neuritis treatment is projected to experience consistent growth. It is forecasted to increase to $2.34 billion by 2029, with a compound annual growth rate (CAGR) of 4.9%. This growth during the forecast period can be linked to several factors such as the proliferation of treatment options, an ageing population, increased obesity rates, high prevalence of HIV/AIDS, expansion in the generic drug market, and initiatives taken by government and healthcare organisations. Significant trends anticipated during the forecast period encompass collaborations and partnerships, advancement in technology, rise in the launching of diabetic peripheral neuritis treatment products, enhanced focus on personalised medicine, the emergence of non-pharmacological therapies, and the incorporation of digital health tools.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21254&type=smp

What Market Forces Are Contributing To The Growth Of The Peripheral Neuritis Treatment Market?

The growth of the peripheral neuritis treatment market is anticipated to be propelled by the escalating occurrence of diabetes. When the body can’t sufficiently regulate blood sugar levels, this chronic medical condition surfaces. Unhealthy dietary habits, sedentary living patterns, obesity, an ageing population, and genetic susceptibility are the reasons for the increasing occurrence of diabetes. Peripheral neuritis treatment aids individuals suffering from diabetes by reducing nerve pain, alleviating inflammation, and boosting nerve functionality which together helps in improving their overall living standards and prevents any future complications. For example, the American Diabetes Association, a US non-profit organization, reported in November 2023 that in 2022, nearly 25.5 million individuals in the U.S. were diagnosed with diabetes, making up 7.6% of the total population. Hence, due to the rising occurrence of diabetes, the peripheral neuritis treatment market is experiencing growth.

Which Segmentation Factors Are Critical In The Peripheral Neuritis Treatment Market Analysis?

The peripheral neuritis treatmentmarket covered in this report is segmented –

1) By Treatment Type: Pharmacological Therapies; Non Pharmacological Therapies

2) By Drug Class: Anti-Depressants; Anticonvulsants; Local Anesthesia; Analgesics; Steroids; Other Drug Classes

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores

4) By Application: Diabetic Peripheral Neuropathy; Chemotherapy-Induced Peripheral Neuropathy; Idiopathic Peripheral Neuropathy; Other Applications

Subsegments:

1) By Pharmacological Therapies: Pain Relievers (Analgesics); Antidepressants; Anticonvulsants; Topical Medications

2) By Non-Pharmacological Therapies: Physical Therapy; Transcutaneous Electrical Nerve Stimulation (TENS); Acupuncture; Lifestyle And Dietary Modifications

How Are Global Trends Impacting The Development Of The Peripheral Neuritis Treatment Market?

Major companies in the peripheral neuritis treatment market are focusing on new therapies like magnetic peripheral nerve stimulation (mPNS) to promote nerve regeneration and reduce neuropathic pain. mPNS is a non-invasive neuromodulation technique that uses magnetic fields to stimulate peripheral nerves, helping alleviate pain, encourage nerve repair, and improve motor function in neuropathy and musculoskeletal disorders. For example, in January 2024, Neuralace Medical Inc., a U.S.-based medical device company, announced FDA approval for Axon Therapy (mPNS) for treating chronic painful diabetic neuropathy (PDN). This therapy offers a quick, painless, non-invasive option for pain relief. Clinical trials showed a 72.3% responder rate at 30 days and 81.4% at 90 days, highlighting its effectiveness in reducing pain and numbness. This approval represents a significant advancement in pain management, providing an alternative to medication with fewer side effects.

Which Organizations Are At The Forefront Of The Peripheral Neuritis Treatment Market?

Major companies operating in the peripheral neuritis treatment market are Pfizer Inc., Johnson & Johnson (J&J), AstraZeneca Plc, Novartis AG, GSK plc, Takeda Pharmaceuticals & Co. Ltd., Eli Lilly and Co., Mallinckrodt Pharmaceuticals plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc., Dr Reddys Laboratories Ltd., Cipla Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Daiichi Sankyo Co. Ltd., Glenmark Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/peripheral-neuritis-treatment-global-market-report

Which Region Is Leading Innovation In The Peripheral Neuritis Treatment Market?

North America was the largest region in the peripheral neuritis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral neuritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21254&type=smp

Browse Through More Reports Similar to the Global Peripheral Neuritis Treatment Market 2025, By The Business Research Company

Neuralgia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

Neuropathic Pain Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Neurotrophic Keratitis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model